SYROS PHARMACEUTICALS, INC.
SYRS US87184Q2066
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-70% | -91% | 120% | -97% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Simonian Nancy A |
0.27 USD |
37,070 Sold |
10,016 USD |
02/12/2024 | 02/12/2024 |
Simonian Nancy A |
0.27 USD |
134,713 Sold |
35,739 USD |
25/11/2024 | 25/11/2024 |
Quirk Gerald E CLO |
0.22 USD |
46,657 Sold |
10,321 USD |
19/11/2024 | 19/11/2024 |
Quirk Gerald E CLO |
0.22 USD |
46,657 Sold |
10,321 USD |
19/11/2024 | 19/11/2024 |
Chee Conley CEO |
0.20 USD |
134,797 Sold |
26,932 USD |
18/11/2024 | 18/11/2024 |
Stephens Kristin BDM |
0.22 USD |
36,133 Sold |
7,949 USD |
18/11/2024 | 18/11/2024 |
Roth David CMO |
0.20 USD |
12,099 Sold |
2,382 USD |
18/11/2024 | 18/11/2024 |
Roth David CMO |
0.20 USD |
12,099 Sold |
2,382 USD |
18/11/2024 | 18/11/2024 |
Chee Conley CEO |
0.20 USD |
134,797 Sold |
26,932 USD |
18/11/2024 | 18/11/2024 |
Stephens Kristin BDM |
0.22 USD |
36,133 Sold |
7,949 USD |
18/11/2024 | 18/11/2024 |